SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"19660107"
 

Sökning: onr:"19660107" > Coffee and tea cons...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00005924naa a22010093a 4500
00119660107
003SE-LIBR
00520160906170230.0
007cr||||||||||||
008160906s2015 sw |||| o |||| ||eng c
0247 a http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1022452 uri
0247 a urn:nbn:se:umu:diva-1022452 urn
0247 a 10.1186/s13058-015-0521-32 doi
040 a S
0410 a eng
042 9 EPLK
1001 a Bhoo-Pathy, Nirmala4 aut
2451 0a Coffee and tea consumption and risk of pre- and postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort studyh [Elektronisk resurs]
260 c 2015
500 a Published
5060 a gratis
520 a Introduction: Specific coffee subtypes and tea may impact risk of pre- and post-menopausal breast cancer differently. We investigated the association between coffee (total, caffeinated, decaffeinated) and tea intake and risk of breast cancer. Methods: A total of 335,060 women participating in the European Prospective Investigation into Nutrition and Cancer (EPIC) Study, completed a dietary questionnaire from 1992 to 2000, and were followed-up until 2010 for incidence of breast cancer. Hazard ratios (HR) of breast cancer by country-specific, as well as cohort-wide categories of beverage intake were estimated. Results: During an average follow-up of 11 years, 1064 premenopausal, and 9134 postmenopausal breast cancers were diagnosed. Caffeinated coffee intake was associated with lower risk of postmenopausal breast cancer: adjusted HR = 0.90, 95% confidence interval (CI): 0.82 to 0.98, for high versus low consumption; P-trend = 0.029. While there was no significant effect modification by hormone receptor status (P = 0.711), linear trend for lower risk of breast cancer with increasing caffeinated coffee intake was clearest for estrogen and progesterone receptor negative (ER-PR-), postmenopausal breast cancer (P = 0.008). For every 100 ml increase in caffeinated coffee intake, the risk of ER-PR- breast cancer was lower by 4% (adjusted HR: 0.96, 95% CI: 0.93 to 1.00). Non-consumers of decaffeinated coffee had lower risk of postmenopausal breast cancer (adjusted HR = 0.89; 95% CI: 0.80 to 0.99) compared to low consumers, without evidence of dose-response relationship (P-trend = 0.128). Exclusive decaffeinated coffee consumption was not related to postmenopausal breast cancer risk, compared to any decaffeinated-low caffeinated intake (adjusted HR = 0.97; 95% CI: 0.82 to 1.14), or to no intake of any coffee (HR: 0.96; 95%: 0.82 to 1.14). Caffeinated and decaffeinated coffee were not associated with premenopausal breast cancer. Tea intake was neither associated with pre- nor post-menopausal breast cancer. Conclusions: Higher caffeinated coffee intake may be associated with lower risk of postmenopausal breast cancer. Decaffeinated coffee intake does not seem to be associated with breast cancer.
650 7a Medical and Health Sciences2 hsv
650 7a Clinical Medicine2 hsv
650 7a Cancer and Oncology2 hsv
650 7a Medicin och hälsovetenskap2 hsv
650 7a Klinisk medicin2 hsv
650 7a Cancer och onkologi2 hsv
7001 a Peeters, Petra H. M.4 aut
7001 a Uiterwaal, Cuno S. P. M.4 aut
7001 a Bueno-de-Mesquita, H. Bas4 aut
7001 a Bulgiba, Awang M.4 aut
7001 a Bech, Bodil Hammer4 aut
7001 a Overvad, Kim4 aut
7001 a Tjønneland, Anne4 aut
7001 a Olsen, Anja4 aut
7001 a Clavel-Chapelon, Francoise4 aut
7001 a Fagherazzi, Guy4 aut
7001 a Perquier, Florence4 aut
7001 a Teucher, Birgit4 aut
7001 a Kaaks, Rudolf4 aut
7001 a Schuetze, Madlen4 aut
7001 a Boeing, Heiner4 aut
7001 a Lagiou, Pagona4 aut
7001 a Orfanos, Philippos4 aut
7001 a Trichopoulou, Antonia4 aut
7001 a Agnoli, Claudia4 aut
7001 a Mattiello, Amalia4 aut
7001 a Palli, Domenico4 aut
7001 a Tumino, Rosario4 aut
7001 a Sacerdote, Carlotta4 aut
7001 a van Duijnhoven, Franzel J. B.4 aut
7001 a Braaten, Tonje4 aut
7001 a Lund, Eiliv4 aut
7001 a Skeie, Guri4 aut
7001 a Redondo, Maria-Luisa4 aut
7001 a Buckland, Genevieve4 aut
7001 a Sanchez Perez, Maria Jose4 aut
7001 a Chirlaque, Maria-Dolores4 aut
7001 a Ardanaz, Eva4 aut
7001 a Amiano, Pilar4 aut
7001 a Wirfalt, Elisabet4 aut
7001 a Wallstrom, Peter4 aut
7001 a Johansson, Ingegerd4 aut
7001 a Nilsson, Lena Maria4 aut
7001 a Khaw, Kay-Tee4 aut
7001 a Wareham, Nick4 aut
7001 a Allen, Naomi E.4 aut
7001 a Key, Timothy J.4 aut
7001 a Rinaldi, Sabina4 aut
7001 a Romieu, Isabelle4 aut
7001 a Gallo, Valentina4 aut
7001 a Riboli, Elio4 aut
7001 a van Gils, Carla H.4 aut
7101 a Umeå universitetb Medicinska fakulteten4 pbl0 268483
7101 a Umeå universitetb Medicinska fakulteten4 pbl0 268483
7721 8i channel recordw 18813935
7730 i Värdpublikationt Breast Cancer Researchg 17x 1465-542X
8564 0u http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-102245
8564 0u http://dx.doi.org/10.1186/s13058-015-0521-3
8564 0u http://umu.diva-portal.org/smash/get/diva2:808310/FULLTEXT01
9102 s6 710,710a Umeå universitet.b Medicinsk-odontologiska fakultetenu Umeå universitet.b Medicinska fakulteten
9102 s6 710,710a Medicinska fakulteten vid Umeå universitetu Umeå universitet.b Medicinska fakulteten
841 5 APISa x ab 160906||0000|||||001||||||000000e 1
0247 5 APISa urn:nbn:se:umu:diva-1022452 urn
852 5 APISb APIS
8564 05 APISu http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-102245

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy